Quarterly Research Grant Funding Programme
This programme funds preclinical and clinical research focused on slowing, stopping, or reversing Parkinson’s. We do not fund research which is directed at symptomatic relief.
Our grant funding process has changed! Due to the discontinuation of Grant Tracker, we will be returning to manual processes for research grant funding submissions. Please review all the guidance below for information on how to apply.
Our funding remit
For preclinical research, we fund grants up to £250,000 (GBP) and prioritise projects that are likely to lead to clinical trials in people with Parkinson’s within 5 years. For clinical research, we fund clinical trials and sub-studies of trials in people with Parkinson’s. The grant amount is flexible but please contact us ahead of submission if you are thinking of applying for a clinical trial.
We fund internationally and accept applications from academics and commercial entities. However, the costs in commercial applications should be justified and equivalent to academic costs where possible.
Our full Research Strategy provides more information on the types of research we fund, our funding priorities and how we provide funding.
If you have any questions about whether your project fits our funding scope, please email us at research@cureparkinsons.org.uk.
New two stage application process:
How to apply for funding
Stage 1 applications should be submitted via email to research@cureparkinsons.org.uk.
All stage 1 application documents can be accessed at the bottom of this page, including:
- Stage 1 application form
- Drug and compound CV (if applicable)
- Commercial entity form (if applicable)
Additional documents that can be included at this stage but are not mandatory and should be provided in their own format:
- Principal investigator/Co-investigator CVs
- Budget breakdown
- Any supplementary documents to support the application (for example, further preliminary data, clinical trial protocol, publications)
Following Research Committee review of stage 1 applications, stage 2 applications will be invited on an individual basis and provided with the necessary documents via email.
The application process
If the proposed project falls within Cure Parkinson’s scope for funding, it will be considered by our independent research committee, which meets on a quarterly basis.
At each meeting, the committee will discuss stage 1 Applications and decide whether they are within remit and should be evaluated further. If they decide that an application should be considered for funding, the applicant will be invited to submit a full application (stage 2) which will subsequently be sent for externally peer review. The feedback from the expert reviews will be discussed at the next quarterly Research Committee meeting, and a recommendation on whether to fund the project will be made for the Cure Parkinson’s trustees to consider. For successful applicants, the process takes approximately three months but can take longer, particularly for clinical trials where an iterative approach may apply.
All successful and unsuccessful applicants will be notified by the chair of the Research Committee and/or a suitable Cure Parkinson’s representative.
Please review the guidance for applicants document below for more information about how to apply and the application and review process. If you have any questions regarding our funding scope, application process or subsequent work with successful applicants, please email the Research Team. Thank you.
2025 application deadlines
Monday 21 July 2025
Monday 3 November 2025
Stage 1 application form
Commercial entity form
Guidance for applicants
Our grant contract
Read our Grant Contract which sets out Cure Parkinson’s terms and conditions to be applied in the event that the application is successful.
